Centre Rene Gauducheau

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Mesothelioma1 trial
• Sarcoma1 trial

Phase

• Phase 21 trial
• Phase 2/31 trial

Status

• Completed2 trials

Lead sponsor

• Canadian Cancer Trials Group1 trial
• Centre Oscar Lambret1 trial

Closed trials

• Completed

  Phase II Study of Regorafenib as Maintenance Therapy

  NCT03793361· Phase 2· Centre Oscar Lambret· Source

• Completed

  Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma

  NCT02784171· Phase 2/3· Canadian Cancer Trials Group· Source